The company now expects its 2024 results to trend towards the higher-end of its previously announced sales guidance range of $10.8B to $11.1B, and adjusted operating EBITDA guidance range of $1.9B to $2.1B. The consensus sales estimate is $11.05B. The company expects volume to trend towards the higher-end of its previously announced 0% to 3% range, with improvements across the majority of the portfolio. Pricing is now expected to increase approximately 1% versus a decline of approximately 2.5%, principally driven by the impact of foreign exchange rate changes in emerging markets where the Company has index pricing to US and/or Euro exchange rates.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IFF: